SLC20A1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SLC20A1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SLC20A1 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | Protein G purified |
| Size | 0.05 mg, 0.1 mg |
| Concentration | n/a |
| Applications | ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Sodium-phosphate symporter which plays a fundamental housekeeping role in phosphate transport, such as absorbing phosphate from interstitial fluid for normal cellular functions such as cellular metabolism, signal transduction, and nucleic acid and lipid synthesis. May play a role in extracellular matrix and cartilage calcification as well as in vascular calcification. May function as a retroviral receptor as it confers human cells susceptibility to infection to Gibbon Ape Leukemia Virus (GaLV), Simian sarcoma-associated virus (SSAV) and Feline leukemia virus subgroup B (FeLV-B) as well as 10A1 murine leukemia virus (10A1 MLV). |
| Immunogen | Immunogen: Recombinant Human Sodium-dependent phosphate transporter 1 protein (263-458AA) |
| Other Names | [Sodium-dependent phosphate transporter 1; Sodium-dependent phosphate transporter 1; Gibbon ape leukemia virus receptor 1; GLVR-1;Leukemia virus receptor 1 homolog; Phosphate transporter 1; PiT-1; Solute carrier family 20 member 1; SLC20A1; GLVR1; PIT1] |
| Gene, Accession # | UniProt: Q8WUM9 |
| Catalog # | MBS7053512 |
| Price | $160, $235 |
| Order / More Info | SLC20A1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies